The antiviral virucidal blocking properties of B would be a huge market if also implemented against yearly cold and viruses. Would like to see more on this effort.
Quote:
"Initial feasibility work to formulate Brilacidin for potential prophylactic use via inhaled delivery, to leverage Brilacidin’s unique virucidal and blocking antiviral properties, also is underway."
It took Mannkind 10 years and a billion dollars to receive the one and only approval for inhalable insulin. They had money, investors, and staff. What’s ipix have?
News 
Market Data 
Discover 
